English

Follow-Up Treatment GOAL Trial B-cell Lymphoma NCT02499003

1 forms  
Admininstrative data
Description

Admininstrative data

Subject-ID
Description

Subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Has the patient received any subsequent lymphoma treatment during follow up?
Description

subsequent lymphoma treatment

Data type

boolean

Follow-Up Lymphoma Treatment
Description

Follow-Up Lymphoma Treatment

No.
Description

Number lymphoma treatment

Data type

integer

Chemotherapy
Description

Chemotherapy

Data type

integer

Antibody
Description

Antibody

Data type

integer

Novel agent
Description

Novel agent

Data type

integer

Consolidation
Description

Consolidation

Data type

integer

Start date
Description

Start date

Data type

date

Stop date
Description

Stop date

Data type

date

Best response
Description

Best response

Data type

integer

Back to the top of the page

Similar models

Follow-Up Treatment GOAL Trial B-cell Lymphoma NCT02499003

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Admininstrative data
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
subsequent lymphoma treatment
Item
Has the patient received any subsequent lymphoma treatment during follow up?
boolean
Item Group
Follow-Up Lymphoma Treatment
Number lymphoma treatment
Item
No.
integer
Item
Chemotherapy
integer
Chemotherapy
Code List
Chemotherapy
CL Item
2-CDA (1)
CL Item
B-ALL-protocol (2)
CL Item
Bendamustine (3)
CL Item
BM (4)
CL Item
CEMP (5)
CL Item
Chlorambucil (6)
CL Item
CHOEP14 (7)
CL Item
CHOEP21 (8)
CL Item
CHOP14 (9)
CL Item
CHOP21 (10)
CL Item
CVP (11)
CL Item
DexaBEAM (12)
CL Item
DHAP (13)
CL Item
DHOAX (14)
CL Item
Etoposide (15)
CL Item
FC (16)
CL Item
Fludarabine (17)
CL Item
Gemcitabine (18)
CL Item
GemOx (19)
CL Item
ICE (20)
CL Item
IEV (21)
CL Item
IMVP16 (22)
CL Item
Knospe (23)
CL Item
MCP (24)
CL Item
Mega-CHOEP (25)
CL Item
Methotrexat (26)
CL Item
Pixantrone (27)
CL Item
R-DHAC (28)
CL Item
Cyclophosphamide (29)
Item
Antibody
integer
Antibody
Code List
Antibody
CL Item
Alemtuzumab (1)
CL Item
lbritumomab (2)
CL Item
Obinutuzumab (3)
CL Item
Ofatumomab (4)
CL Item
Rituximab (5)
Item
Novel agent
integer
Novel agent
Code List
Novel agent
CL Item
Bortezomib (1)
CL Item
Everolimus (2)
CL Item
lbrutinib (3)
CL Item
ldelalisib (4)
CL Item
Lenalidomid (5)
CL Item
Temsirolimus (6)
CL Item
Venetoclax (7)
Item
Consolidation
integer
Consolidation
Code List
Consolidation
CL Item
BEAM (1)
CL Item
BEAC (2)
CL Item
lbritumomab (3)
CL Item
TBI/Cy (4)
CL Item
Transplant: full allo (5)
CL Item
Transplant: mini allo (6)
CL Item
other conditioning (7)
CL Item
Hd-BM (Carmustin/Melphalan) (8)
Start date
Item
Start date
date
Stop date
Item
Stop date
date
Item
Best response
integer
Best response
Code List
Best response
CL Item
CR (1)
CL Item
CRu (2)
CL Item
PR (3)
CL Item
SD (4)
CL Item
PD (5)
CL Item
Discontinued (6)
CL Item
Unknown (7)
Back to the top of the page